CDK4 and gastric cancer: To test whether a demethylation agent could improve PAX6‐induced CDK4/6i resistance, the response of CDK4/6i palbociclib and 5‐Aza in AGS GC cells transfected with vector or PAX6, and in HGC27 GC cells with or without PAX6 knockdown, was compared.